Notifications
2016_01_28 Data Snapshot
Table 1. Get Full Table
| Barcode | UUID | Date | Type | Category | Notes |
|---|---|---|---|---|---|
| TCGA-CD-5813 | 152b9d8a-19fd-4665-b9e4-4fedfb1608cd | 03/13/2011 | STAD | Item in special subset | Sample is Signet Ring subtype. Program Office determined this will be a Notification. |
| TCGA-CG-4444 | 5c087d33-0bd3-407d-8350-fabba6aec597 | 10/31/2012 | STAD | Prior malignancy | Prior malignancy bladder cancer. No systemic chemotherapy or radiation. |
| TCGA-CG-4460 | 3c3d4ef0-019a-423e-89b2-4ac5a7b567ab | 10/31/2012 | STAD | Prior malignancy | Prior malignancy ovarian cancer treated with chemotherapy. |
| TCGA-CG-4460 | 3c3d4ef0-019a-423e-89b2-4ac5a7b567ab | 11/10/2012 | STAD | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy ovarian cancer treated with chemotherapy. |
| TCGA-CG-4475 | cad2adc1-0f41-4651-9c80-ae9961e2dc8d | 10/31/2012 | STAD | Prior malignancy | Prior malignancy of the prostate, bladder, and testicle. No systemic chemotherpay or radiation. |
| TCGA-CG-4476 | 442d7415-d095-4962-8296-a14390bad40a | 10/31/2012 | STAD | Prior malignancy | Prior malignancy of the prostate. No systemic chemotherpay or radiation. |
| TCGA-CG-5716 | 49587564-e30f-4f1c-b7b3-fc0989bb1a0a | 10/31/2012 | STAD | Prior malignancy | Prior malignancy prostate cancer treated with chemotherapy and radiation. |
| TCGA-CG-5716 | 49587564-e30f-4f1c-b7b3-fc0989bb1a0a | 11/10/2012 | STAD | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy prostate cancer treated with chemotherapy and radiation. |
| TCGA-CG-5727 | b75eb694-8e9d-4dbb-b536-7d278c728cbb | 05/17/2013 | STAD | Synchronous malignancy | Patient had a synchronous malignant neoplasm of the colon. No systemic radation or chemotherapy. |
| TCGA-EQ-A4SO | fe1ad544-3189-4495-86be-0c68f3234238 | 02/22/2013 | STAD | Prior malignancy | Patient had a prior basal cell carcinoma of the skin. No radiation or systemic chemotherapy. |
| TCGA-F1-6177 | c3cba26e-38c2-4569-afd6-6b045e604808 | 10/31/2012 | STAD | Prior malignancy | Prior malignancy prostate cancer. No systemic chemotherapy or radiation. |
| TCGA-HF-7131 | 06fd3086-0801-4d74-bced-4916efc544d2 | 10/31/2012 | STAD | Prior malignancy | Prior malignancy R breast cancer treated with Epirubicin Hydrochloride, Fluorouracil, Cyclophosphamide, Docetaxel, and Tamoxifen Citrate. |
| TCGA-HF-7131 | 06fd3086-0801-4d74-bced-4916efc544d2 | 11/10/2012 | STAD | History of unacceptable prior treatment related to a prior/other malignancy | Prior malignancy R breast cancer treated with Epirubicin Hydrochloride, Fluorouracil, Cyclophosphamide, Docetaxel, and Tamoxifen Citrate. |
| TCGA-HU-A4H6 | 416fd59b-a4f8-4610-9f8b-473cb5c04a4a | 08/04/2015 | STAD | Neoadjuvant therapy | Dates on Enrollment and Pharmaceutical forms are inconsistent. Neoadjuvant therapy prior to TCGA procurement can not be verified as TSS is non-responsive. |
| TCGA-IC-A6RF | 9dfddc49-1e66-4e26-9d71-40d748cca0a6 | 08/26/2014 | ESCA | History of unacceptable prior treatment related to a prior/other malignancy | During Enrollment it was found that the patient had a prior right breast malignancy and recieved systemic pharma treatment (cytoxan and taxotere). |
| TCGA-L5-A43M | 29da08f4-c9e2-4e7a-9733-b4ec5b9c5f13 | 02/01/2013 | ESCA | Prior malignancy | Patient had a prior colon cancer. No radiation or systemic chemotherapy. |
| TCGA-L5-A88T | 6826bcdd-24a4-4dd1-9fab-201cf774e166 | 06/16/2014 | ESCA | History of unacceptable prior treatment related to a prior/other malignancy | systemic treatment given to the prior/other malignancy |
| TCGA-V5-A7RE-11A | 7c5a7626-d549-45c0-ae47-5dee771ac0b0 | 01/19/2015 | ESCA | Item does not meet study protocol | The External pathology Committee determined this normal sample contained tumor per frozen slide review and it was verified by internal BCR pathologists and should not have shipped. |
| TCGA-V5-A7RE-11A | 7c5a7626-d549-45c0-ae47-5dee771ac0b0 | 01/20/2015 | ESCA | Pathology outside specification | The External pathology Committee determined this normal sample contained tumor per frozen slide review and it was verified by internal BCR pathologists and should not have shipped. |